Baxter International Inc. provides a portfolio of healthcare products. The company operates through North and South America; Europe, Middle East and Africa; and Asia-Pacific segments. It offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; renal replacement therapies and other organ support therapies focused in the intensive care unit; sterile intravenous (IV) solutions, IV therapies, infusion pumps, administration sets, and drug reconstitution devices; and parenteral nutrition therapies. The company also provides biological products and medical devices, and surgical hemostat and sealant products used in surgical procedures for hemostasis, tissue sealing, and adhesion prevention; premixed and oncology drug platforms, inhaled anesthesia and critical care products, and pharmacy compounding services; and generic injectable pharmaceuticals. Its products are used in hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and by patients at home under physician supervision. The company sells its products through direct sales force, independent distributors, drug wholesalers, and specialty pharmacy or other alternate site providers in approximately 100 countries. It has an agreement with Celerity Pharmaceutical, LLC to develop acute care generic injectable premix and oncolytic molecules. Baxter International Inc. was founded in 1931 and is headquartered in Deerfield, Illinois.
Industry, Sector and Symbol
Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Phone224-948-2000
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$11.13 billion
Profitability
Miscellaneous
Employees47,000
Next Earnings Date4/25/2019 (Estimated)
OptionableOptionable
Baxter International (NYSE:BAX) Frequently Asked Questions
What is Baxter International's stock symbol?
Baxter International trades on the New York Stock Exchange (NYSE) under the ticker symbol "BAX."
How often does Baxter International pay dividends? What is the dividend yield for Baxter International?
Baxter International declared a quarterly dividend on Tuesday, February 19th. Investors of record on Friday, March 1st will be given a dividend of $0.19 per share on Monday, April 1st. This represents a $0.76 dividend on an annualized basis and a yield of 1.03%. The ex-dividend date is Thursday, February 28th. View Baxter International's Dividend History.
How will Baxter International's stock buyback program work?
Baxter International declared that its board has approved a stock repurchase program on Tuesday, November 13th 2018, which allows the company to buyback $2,000,000,000.00 in shares, according to EventVestor. This buyback authorization allows the company to reacquire up to 6.1% of its shares through open market purchases. Shares buyback programs are usually an indication that the company's leadership believes its shares are undervalued.
How were Baxter International's earnings last quarter?
Baxter International Inc (NYSE:BAX) released its earnings results on Thursday, January, 31st. The medical instruments supplier reported $0.78 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of $0.73 by $0.05. The medical instruments supplier earned $2.84 billion during the quarter, compared to analysts' expectations of $2.80 billion. Baxter International had a return on equity of 18.46% and a net margin of 14.60%. View Baxter International's Earnings History.
When is Baxter International's next earnings date?
What guidance has Baxter International issued on next quarter's earnings?
Baxter International updated its FY19 earnings guidance on Thursday, January, 31st. The company provided earnings per share guidance of $3.22-3.30 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.27. The company issued revenue guidance of ~$11.1-11.2 billion, compared to the consensus revenue estimate of $11.37 billion.Baxter International also updated its FY 2019 guidance to $3.22-3.30 EPS.
What price target have analysts set for BAX?
15 analysts have issued 1 year price objectives for Baxter International's stock. Their predictions range from $70.00 to $85.00. On average, they anticipate Baxter International's share price to reach $76.3333 in the next twelve months. This suggests a possible upside of 3.1% from the stock's current price. View Analyst Price Targets for Baxter International.
What is the consensus analysts' recommendation for Baxter International?
15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Baxter International in the last year. There are currently 3 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Baxter International.
Has Baxter International been receiving favorable news coverage?
Media headlines about BAX stock have been trending somewhat positive on Thursday, InfoTrie Sentiment reports. The research group identifies negative and positive news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Baxter International earned a coverage optimism score of 0.6 on InfoTrie's scale. They also assigned news stories about the medical instruments supplier a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future.
Who are some of Baxter International's key competitors?
Some companies that are related to Baxter International include 3M (MMM), Stryker (SYK), Becton Dickinson and (BDX), Boston Scientific (BSX), FRESENIUS SE &/S (FSNUY), ABIOMED (ABMD), ResMed (RMD), Teleflex (TFX), DexCom (DXCM), Hill-Rom (HRC), ICU Medical (ICUI), Insulet (PODD), Penumbra (PEN), Novocure (NVCR) and Globus Medical (GMED).
What other stocks do shareholders of Baxter International own?
Who are Baxter International's key executives?
Baxter International's management team includes the folowing people:
- Mr. José E. Almeida, Chairman, Pres & CEO (Age 57)
- Mr. James K. Saccaro, Exec. VP & CFO (Age 46)
- Mr. Sean Martin, Sr. VP & Gen. Counsel (Age 56)
- Mr. Brik V. Eyre, Sr. VP & Pres of Americas (Age 55)
- Mr. Giuseppe Accogli, Sr. VP & Pres of Global Bus.es (Age 48)
Who are Baxter International's major shareholders?
Baxter International's stock is owned by a variety of of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.29%), Third Point LLC (5.26%), Northern Trust Corp (1.62%), Geode Capital Management LLC (1.21%), Harris Associates L P (1.05%) and Standard Life Aberdeen plc (0.98%). Company insiders that own Baxter International stock include Albert P L Stroucken, Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Institutional Ownership Trends for Baxter International.
Which major investors are selling Baxter International stock?
BAX stock was sold by a variety of institutional investors in the last quarter, including Third Point LLC, Two Sigma Advisers LP, APG Asset Management N.V., Harris Associates L P, Canada Pension Plan Investment Board, BlackRock Inc., Standard Life Aberdeen plc and Smith Asset Management Group LP. Company insiders that have sold Baxter International company stock in the last year include Brik V Eyre, Carole J Shapazian, Giuseppe Accogli, James R Gavin III, Jeanne K Mason, John D Forsyth, Peter S Hellman, Scott Pleau, Third Point Llc and Thomas T Stallkamp. View Insider Buying and Selling for Baxter International.
Which major investors are buying Baxter International stock?
BAX stock was acquired by a variety of institutional investors in the last quarter, including Oregon Public Employees Retirement Fund, State of Tennessee Treasury Department, California Public Employees Retirement System, Mackenzie Financial Corp, State of New Jersey Common Pension Fund D, Eaton Vance Management, Mawer Investment Management Ltd. and Bessemer Group Inc.. View Insider Buying and Selling for Baxter International.
How do I buy shares of Baxter International?
Shares of BAX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Baxter International's stock price today?
One share of BAX stock can currently be purchased for approximately $74.03.
How big of a company is Baxter International?
Baxter International has a market capitalization of $39.39 billion and generates $11.13 billion in revenue each year. The medical instruments supplier earns $1.62 billion in net income (profit) each year or $3.05 on an earnings per share basis. Baxter International employs 47,000 workers across the globe.
What is Baxter International's official website?
How can I contact Baxter International?
Baxter International's mailing address is One Baxter Parkway, DEERFIELD IL, 60015. The medical instruments supplier can be reached via phone at 224-948-2000 or via email at [email protected]
MarketBeat Community Rating for Baxter International (NYSE BAX)
MarketBeat's community ratings are surveys of what our community members think about Baxter International and other stocks. Vote "Outperform" if you believe BAX will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAX will underperform the S&P 500 over the long term. You may vote once every thirty days.
